5 nominees · 6 ballot items.
Elect five directors; ratify appointment of Carr, Riggs & Ingram as independent registered public accounting firm; approve one or more reverse stock splits (1-for-2 to 1-for-100, aggregate not more than 1-for-500) by amendment of the Certificate of Incorporation; approve issuance of shares for purposes of Nasdaq Listing Rule 5635 related to a senior secured convertible note and warrants issued to J.J. Astor & Co.; approve issuance of up to 12,131,770 shares issuable upon exercise of certain pre-funded warrants issued in connection with a Sarborg purchase; and approve adjournment/postponement of the Annual Meeting if necessary to continue soliciting votes for the listed proposals.
Elect five nominees (Andrew Regan, Ulrik Olsen, James Bligh, Chele Chiavacci Farley and Simon Fry) to serve as directors for one-year terms expiring at the next annual meeting.
Ratify the Board’s appointment of Carr, Riggs & Ingram, L.L.C. (CRI) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Approve amendments to the Company’s Certificate of Incorporation authorizing the Board to implement one or more reverse stock splits of the Common Stock at whole-number ratios between 1-for-2 and 1-for-100 (and in the aggregate not more than 1-for-500), with the Board able to determine the exact ratio(s) and to abandon any amendment prior to filing.
This management proposal asks shareholders to authorize one or more charter amendments to permit the Board to implement reverse stock splits of the Company’s common stock at whole-number ratios between 1-for-2 and 1-for-100, with an aggregate cap of 1-for-500, and to give the Board discretion to choose the ratio(s) and to abandon any approved amendment before filing. Management frames the request as a tool to preserve Nasdaq listing compliance (minimum bid price) and to increase institutional and broker-dealer interest by producing a higher per-share stock price, which could also make the stock more attractive to funds, analysts and employee recruitment. The Board emphasizes it would not be obligated to enact any reverse split even if approved, reserving the right to implement none, one, or multiple splits as market conditions dictate; this dual-step approach gives flexibility but also transfers substantial timing and ratio discretion to management. Key risks highlighted include the possibility that a reverse split may not sustain a higher trading price, possible reductions in liquidity due to fewer shares outstanding, and the potential anti‑takeover effects from increasing the pool of unissued authorized shares. The proposal preserves authorized share counts and provides for cash-out of fractional shares at the pre-split market price; it also notes U.S. federal income tax considerations and that Delaware law requires stockholder approval of charter amendments. For an analyst evaluating this measure, the proposal is governance-light in that it centralizes implementation discretion with the Board — useful in rapid-response scenarios to avoid Nasdaq deficiency notices, but it warrants close monitoring of board decision-making and communication about when and why any split is executed. The Board’s recommendation in favor is based on preserving listing status and potentially enhancing marketability; shareholders should weigh that potential benefit versus the dilution dynamics associated with outstanding warrants and convertible securities and the historical uncertainty about the price impact of reverse splits in similarly situated small-cap firms.
Seek shareholder approval under Nasdaq Listing Rule 5635 for the potential issuance of shares upon conversion of a senior secured convertible note and exercise of related common stock purchase warrants issued to J.J. Astor & Co., because the potential issuance could exceed Nasdaq’s 19.99% threshold.
This management proposal requests Nasdaq Rule 5635 shareholder approval to permit issuance of shares upon conversion of a senior secured convertible note and upon exercise of associated warrants issued to J.J. Astor & Co. because the potential issuance could exceed Nasdaq’s 19.99% threshold. The financing provided upfront cash and contains conversion terms tied to VWAP measures and Nasdaq floor-price protections; conversion prices are defined as formulas (initially the greater of 90% of the lowest 10-day VWAP or Nasdaq floor, later amended to 70% of 20-day VWAP or the Nasdaq floor under the Amended Agreements) with beneficial ownership caps (initially 4.99%, convertible to 9.99% at the lender’s option) to limit immediate control shifts. The Note includes default protections that increase principal to 120% and apply a 19% default rate, and the related warrants carry multi-year exercise windows and specified exercise prices; amendments further changed the principal and warrant counts. Management frames the request as required regulatory housekeeping to permit the agreed financing to operate while complying with Nasdaq rules, and recommends approval to preserve access to the financing. For an analyst, the proposal’s material governance and capital-structure impact centers on dilution risk (potential issuance of a substantial fraction of outstanding shares), conversion pricing mechanics tied to VWAP that could produce a significant number of shares if the stock trades at low prices, and restrictive default terms that could accelerate dilution. The Board’s recommendation to approve reflects the strategic need for committed capital and the company’s view that the transaction’s terms and controls are acceptable; however, shareholders should consider the potential short- and long-term dilutive effects, the interplay with other outstanding convertible instruments and pre-funded warrants, and the risk that favorable conversion formulas combined with low trading prices could magnify dilution.
Authorize issuance, for Nasdaq Rule 5635 purposes, of up to 12,131,770 shares of common stock issuable upon exercise of pre-funded warrants issued to certain investors in connection with the Company’s purchase of Sarborg shares, because the potential issuance exceeds Nasdaq’s 19.99% threshold.
This management proposal seeks shareholder approval under Nasdaq Listing Rule 5635 to authorize the potential issuance of up to 12,131,770 shares upon exercise of pre-funded warrants issued to certain Sarborg shareholders as part of the Company’s acquisition of a minority stake in Sarborg. The pre-funded warrants carry a nominal exercise price ($0.0001) and are currently not exercisable until stockholder approval is obtained, but because they represent more than 19.99% of the outstanding common shares at issuance, Nasdaq approval is required. Management argues the issuance is part of a strategic acquisition of Sarborg equity and that Board approval to permit exercise is necessary to complete the commercial and contractual terms of the purchase agreement. From a capital-structure perspective, the potential exercise would be highly dilutive — issuing over twelve million shares against a small outstanding base — and would materially reduce current holders’ percentage ownership and could depress per-share metrics. The transaction includes beneficial ownership limits on exercise and other contractual restrictions, but shareholders must weigh operational/strategic benefits of the Sarborg acquisition (including access to Sarborg services or IP) against the immediate dilution and potential market reaction. The Board’s recommendation to approve indicates management prioritizes completing the Sarborg transaction and having the flexibility to permit exercise; sophisticated investors should seek clarity on the strategic rationale, expected benefits from the Sarborg stake, and any contingencies or protective steps to mitigate dilution impact.
Authorize the Board to adjourn or postpone the Annual Meeting, if necessary, to continue soliciting votes to obtain approval for Proposals Nos. 1–5.
Proposal No. 6 seeks a stockholder authorization to allow the Board to adjourn or postpone the Annual Meeting if needed to continue soliciting votes to obtain approval for Proposals 1–5. While procedural in nature, the authority to adjourn is practically important for management because several material proposals (including reverse split and Nasdaq-related issuances) may require additional votes or time to secure approval, and adjourning allows management to continue outreach without reconvening a new meeting. The Company states it does not currently intend to adjourn if sufficient votes are received, but asks for the contingency power to prevent a failed meeting where critical funding and corporate-governance proposals remain unresolved. For an analyst, voting to permit adjournment is typically low-risk and aligns with shareholder interests in avoiding the cost and delay of reconvening a separate special meeting; however, repeated adjournments can delay resolution of sensitive matters and may reflect insufficient early shareholder support. The Board recommends a “FOR” vote to preserve flexibility to complete the solicitation and to protect against the operational and financial consequences of proposals failing due to insufficient votes.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | JANE STREET GROUP, LLC | 5.12% | 40,270 | $23K |
| 2 | CITADEL ADVISORS LLC | 4.11% | 32,295 | $18K |
| 3 | Virtu Financial LLC | 3.46% | 27,244 | $15K |
| 4 | JANE STREET GROUP, LLC | 2.66% | 20,920 | $12K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.13% | 16,739 | $9K |
| 6 | XTX Topco Ltd | 1.64% | 12,916 | $7K |
| 7 | Financial Management Professionals, Inc. | 1.27% | 10,005 | $6K |
| 8 | Tower Research Capital LLC (TRC | 0.82% | 6,416 | $4K |
| 9 | Tower Research Capital LLC (TRC | 0.34% | 2,679 | $2K |
| 10 | Caitong International Asset Management Co., Ltd | 0.00% | 1 | $1 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.